Scout says it made the 2026 Inc. 5000 list for a second year

Scout said on Aug. 11 that it was included on the 2026 Inc. 5000 list of the fastest-growing private companies in America for the second year in a row.

The Dallas-based company said the repeat listing reflects continued demand for its services and technology used in pharma and biotech clinical trials. Scout said it helps sponsors, contract research organizations, sites and participants manage operational work in studies.

Scout said it operates in more than 100 countries and offers face-to-face, virtual and hybrid clinical meeting planning, patient payment, travel and logistics support, and site-focused services. The company said it has also expanded its Site Engagement presence internationally over the past year.

In the announcement, Scout said the broader reach is meant to strengthen support for investigator sites across regions, languages and study requirements. It also said it invested in technology this year, including UX and UI updates to the Scout Portal and enhanced mobile app access.

CEO Moisha Platto said the second year on the list tells “a more complete story.” He said staying on the list takes “discipline, investment, and a clear understanding of what our partners need as clinical trials become more global and more operationally complex.”

Scout did not disclose its Inc. 5000 rank, growth rate or revenue in the release. The company said it has worked to make clinical trial participation easier to manage for more than 30 years.

The announcement is based on Scout’s own release, dated Aug. 11 and datelined Dallas. Inc. is published by Mansueto Ventures LLC.

What happens next was not detailed in the release. Scout said it will continue supporting clinical trial work across its global network and through updates to its portal and mobile access.

Sources

• PR Newswire: Scout named to Inc. 5000 list for second consecutive year

Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.